Filing Flows › PTC Therapeutics (PTCT) › Recalls, complaints & regulation
PTC Therapeutics (PTCT): clinical trials
PTC Therapeutics (PTCT) beyond its filings: 5 active clinical trials.
PTC Therapeutics' latest quarter
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does PTC Therapeutics have?
5 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.